Cited by 565Thyroid Cancer Diagnosis and TreatmentIdentification and Quantification in FoodCervical Cancer and HPV Research

The DOI matches its Crossref record; 84 of the 86 references it cites were found in a registry or an index.

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Open access

Schweppe, Rebecca E., Klopper, Joshua P., Korch, Christopher, Pugazhenthi, Umarani, Benezra, Miriam, Knauf, Jeffrey A., Fagin, James A., Marlow, Laura A., Copland, John A., Smallridge, Robert C., Haugen, Bryan R.·2008·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2008-1102PMC PMC2582569

Open this paper in CoChat — free account Open PDF

Abstract

CONTEXT: Cell lines derived from human cancers provide critical tools to study disease mechanisms and develop novel therapies. Recent reports indicate that up to 36% of cell lines are cross- contaminated. OBJECTIVE: We evaluated 40 reported thyroid cancer-derived cell lines using short tandem repeat and single nucleotide polymorphism array analysis. RESULTS: Only 23 of 40 cell lines tested have unique genetic profiles. The following groups of cell lines are likely derivatives of the same cell line: BHP5-16, BHP17-10, BHP14-9, and NPA87; BHP2-7, BHP10-3, BHP7-13, and TPC1; KAT5, KAT10, KAT4, KAT7, KAT50, KAK1, ARO81-1, and MRO87-1; and K1 and K2. The unique cell lines include BCPAP, KTC1, TT2609-C02, FTC133, ML1, WRO82-1, 8505C, SW1736, Cal-62, T235, T238, Uhth-104, ACT-1, HTh74, KAT18, TTA1, FRO81-2, HTh7, C643, BHT101, and KTC-2. The misidentified cell lines included the DRO90-1, which matched the melanoma-derived cell line, A-375. The ARO81-1 and its derivatives matched the HT-29 colon cancer cell line, and the NPA87 and its derivatives matched the M14/MDA-MB-435S melanoma cell line. TTF-1 and Pax-8 mRNA levels were determined in the unique cell lines. CONCLUSIONS: Many of these human cell lines have been widely used in the thyroid cancer field for the past 20 yr and are not only redundant, but not of thyroid origin. These results emphasize the importance of cell line integrity, and provide the short tandem repeat profiles for a panel of thyroid cancer cell lines that can be used as a reference for comparison of cell lines from other laboratories.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2008-1102

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
Melillo, R. M., Castellone, M. D., Guarino, V., Falco, V. D., Cirafici, A. M., Salvatore, G., Caiazzo, F., Basolo, F., Giannini, R., Kruhøffer, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87345 · Cited by 305
Retracted
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
Melillo, R. M., Castellone, M. D., Guarino, V., Falco, V. D., Cirafici, A. M., Salvatore, G., Caiazzo, F., Basolo, F., Giannini, R., Kruhøffer, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22758 · Cited by 298
Retracted
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2
Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,336
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510
Self-citation
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,036
Self-citation
New Human Tumor Cell Lines
Fogh, J., & Trempe, G. (1975) · Springer eBooks · doi:10.1007/978-1-4757-1647-4_5 · Cited by 1,034
Molecular characterization of human prostate carcinoma cell lines
van Bokhoven, A., Varella‐Garcia, M., Korch, C. T., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 635
Self-citation
Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers
Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T., Ohtsuru, A., Saenko, V., Kanematsu, T., & Yamashita, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030305 · Cited by 532
Short tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478

Flagged first, then by citations

Show all 86 references

2 of the 86 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Hay, 1984, Banking and strain data of cell cultures., In vitro TCA Monograph, 5, 215
Ain, 1992, Characterization of an immortalized cell-line (KAK-1) from a benign human thyroid follicular adenoma, Thyroid, 2, S49

Sorted by citations

Items 201–300 of 565

The PTTG1-Binding Factor (PBF/PTTG1IP) Regulates p53 Activity in Thyroid Cells
Read, M. L., Seed, R., Fong, J. C., Modasia, B., Ryan, G. A., Watkins, R. J., Gagliano, T., Smith, V. E., Stratford, A. L., Kwan, P., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1646 · Cited by 39
Aberrant BRAF splicing as an alternative mechanism for oncogenic B‐Raf activation in thyroid carcinoma
Baitei, E. Y., Zou, M., Al-Mohanna, F. A., Collison, K., Alzahrani, A. S., Farid, N. R., Meyer, B. F., & Shi, Y. (2008) · The Journal of Pathology · doi:10.1002/path.2496 · Cited by 39
LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma
Zhao, S., Wang, Q., Li, Z., Ma, X., Wu, L., Ji, H., & Qin, G. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0265-z · Cited by 40
SNAIL Induces Epithelial-to-Mesenchymal Transition and Cancer Stem Cell–Like Properties in Aldehyde Dehydroghenase–Negative Thyroid Cancer Cells
Yasui, K., Shimamura, M. I., Mitsutake, N., & Nagayama, Y. (2013) · Thyroid · doi:10.1089/thy.2012.0319 · Cited by 38
Proteasome Inhibition Induces a p38 MAPK Pathway-Dependent Antiapoptotic Program via Nrf2 in Thyroid Cancer Cells
Du, Z., Yan, Y., Zhang, H., Liu, B.-Q., Gao, Y., Niu, X., Meng, X., & Wang, H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2642 · Cited by 37
Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers
Hardin, H. A., Montemayor, C., & Lloyd, R. V. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.01.009 · Cited by 38
Expression of the DNA-dependent protein kinase catalytic subunit is associated with the radiosensitivity of human thyroid cancer cell lines
Ihara, M., Ashizawa, K., Shichijo, K., & Kudo, T. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rry097 · Cited by 38
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity
Sorriento, D., Campanile, A., Santulli, G., Leggiero, E., Pastore, L., Trimarco, B., & Iaccarino, G. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-97 · Cited by 38
MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma
Romitti, M., Wajner, S. M., Ceolin, L., Ferreira, C. V., Ribeiro, R. V. P., Rohenkohl, H. C., Weber, S. D. S., Lopez, P. L. D. C., Fuziwara, C. S., Kimura, E. T., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-15-0162 · Cited by 38
TGFβ induces epithelial‐mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways
Baquero, P., Jiménez‐Mora, E., Santos, A. R. S., Lasa, M., & Chiloeches, A. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22415 · Cited by 38
ΔNp73α inhibits PTEN expression in thyroid cancer cells
Vella, V., Puppin, C., Damante, G., Vigneri, R., Sanfilippo, M., Vigneri, P. G., Tell, G., & Frasca, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.24221 · Cited by 37
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
Pozdeyev, N. V., Berlinberg, A. J., Zhou, Q., Wuensch, K. E., Shibata, H., Wood, W. M., & Haugen, B. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134901 · Cited by 37
Self-citation
PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma
Passaro, C., Volpe, M., Botta, G., Scamardella, E., Perruolo, G., Gillespie, D. A., Libertini, S., & Portella, G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.022 · Cited by 37
4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas
Varinelli, L., Caccia, D., Volpi, C. C., Caccia, C., Bortoli, M. D., Taverna, E., Gualeni, A. V., Leoni, V., Gloghini, A., Manenti, G., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0299 · Cited by 37
Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer
Plantinga, T. S., Tesselaar, M. H., Morreau, H. M., Corssmit, E. P. M., Willemsen, B. K., Küsters, B., Grunsven, A. C. H. V. E., Smit, J. W. A., & Netea-Maier, R. T. (2016) · Autophagy · doi:10.1080/15548627.2016.1174802 · Cited by 37
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells
Maggisano, V., Celano, M., Lombardo, G. E., Lepore, S. M., Sponziello, M., Rosignolo, F., Verrienti, A., Baldan, F., Puxeddu, E., Durante, C., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.007 · Cited by 37
Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
Kumarasamy, V. M., Shin, Y.-J., White, J., & Sun, D. (2015) · BMC Cancer · doi:10.1186/s12885-015-1610-5 · Cited by 36
Vitamin C Cytotoxicity and Its Effects in Redox Homeostasis and Energetic Metabolism in Papillary Thyroid Carcinoma Cell Lines
Tronci, L., Serreli, G., Piras, C., Frau, D. V., Dettori, T., Deiana, M., Murgia, F., Santoru, M. L., Spada, M., Leoni, V. P., et al. (2021) · Antioxidants · doi:10.3390/antiox10050809 · Cited by 36
Iodide- and Glucose-Handling Gene Expression Regulated by Sorafenib or Cabozantinib in Papillary Thyroid Cancer
Ruan, M., Liu, M., Dong, Q., & Chen, L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3023 · Cited by 36
Foxo3a drives proliferation in anaplastic thyroid carcinoma via transcriptional regulation of cyclin A1: A paradigm shift that impacts current therapeutic strategies
Marlow, L. A., Roemeling, C. A. V., Cooper, S. J., Zhang, Y., Rohl, S. D., Arora, S., Gonzales, I. M., Azorsa, D. O., Reddi, H. V., Tun, H. W., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.097428 · Cited by 36
Self-citation
1,25-Dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer
Clinckspoor, I., Verlinden, L., Overbergh, L., Korch, C. T., Bouillon, R., Mathieu, C., Verstuyf, A., & Decallonne, B. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.008 · Cited by 35
Self-citation
Stem Cells and Cancer Stem-Like Cells in Endocrine Tissues
Lloyd, R. V., Hardin, H. A., Montemayor, C., Rotondo, F., Syro, L. V., Horváth, É., & Kovács, K. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9235-1 · Cited by 35
Methylation of DACT2 Promotes Papillary Thyroid Cancer Metastasis by Activating Wnt Signaling
Zhao, Z., Herman, J. G., Brock, M. V., Sheng, J., Zhang, M., Liu, B., & Guo, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112336 · Cited by 35
Role of glutaminyl cyclases in thyroid carcinomas
Kehlen, A., Haegele, M., Menge, K., Gans, K., Immel, U., Hoang‐Vu, C., Klonisch, T. C., & Demuth, H. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0053 · Cited by 35
Identification and characterization of two novel oncogenic mTOR mutations
Murugan, A. K., Liu, R., & Xing, M. (2019) · Oncogene · doi:10.1038/s41388-019-0787-5 · Cited by 35
Effects of curcumin and its adjuvant on TPC1 thyroid cell line
Esposito, T., Lucariello, A., Hay, E., Contieri, M., Pasquale, T., Varriale, B., Guerra, G., Luca, A. D., & Perna, A. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.031 · Cited by 35
The hsp70 inhibitor VER155008 induces paraptosis requiring de novo protein synthesis in anaplastic thyroid carcinoma cells
Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., & Lee, S. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.060 · Cited by 37
Development and Characterization of Six New Human Papillary Thyroid Carcinoma Cell Lines
Henderson, Y. C., Ahn, S., Ryu, J., Chen, Y., Williams, M. D., El‐Naggar, A. K., Gagea, M., Schweppe, R. E., Haugen, B. R., Lai, S. Y., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2624 · Cited by 35
Self-citation
Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas
Degl’Innocenti, D., Alberti, C., Castellano, G., Greco, A., Miranda, C., Pierotti, M. A., Seregni, E. C., Borrello, M. G., Canevari, S., & Tomassetti, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012701 · Cited by 35
Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3
Bartolazzi, A., D’Alessandria, C., Parisella, M. G., Signore, A., Prete, F. D., Lavra, L., Braesch‐Andersen, S., Massari, R., Trotta, C., Soluri, A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003768 · Cited by 34
First Evaluation of the Biologic Effectiveness Factors of Boron Neutron Capture Therapy (BNCT) in a Human Colon Carcinoma Cell Line
Dagrosa, M. A., Crivello, M., Perona, M., Thorp, S. I., Cruz, G. A. S., Pozzi, E. C. C., Casal, M., Thomasz, L., Cabrini, R. L., Kahl, S. B., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.020 · Cited by 34
Off-Target Effects of c-MET Inhibitors on Thyroid Cancer Cells
Zhou, Y., Zhao, C., Gery, S., Braunstein, G. D., Okamoto, R., Alvarez, R., Miles, S. A., Doan, N., SAID, J. W., Gu, J., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0187 · Cited by 34
Anaplastic thyroid cancer: a comprehensive review of novel therapy
Kojic, S. L., Strugnell, S. S., & Wiseman, S. M. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.179 · Cited by 34
Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells
Jensen, K. E., Bikas, A., Patel, A. D., Kushchayeva, Y. S., Costello, J., McDaniel, D. P., Burman, K. D., & Vasko, V. V. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0568 · Cited by 34
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF V600E by synergistically decreasing global trimethylation of H3K27
Fu, H., Cheng, L., Sa, R., Jin, Y., & Chen, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15007 · Cited by 34
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
Aydemirli, M. D., van Eendenburg, J. D. H., van Wezel, T., Oosting, J., Corver, W. E., Kapiteijn, E., & Morreau, H. M. (2021) · Endocrine Related Cancer · doi:10.1530/erc-20-0436 · Cited by 34
PPAR γ Promotes Growth and Invasion of Thyroid Cancer Cells
Wood, W. M., Sharma, V., Bauerle, K. T., Pike, L. A., Zhou, Q., Fretwell, D. L., Schweppe, R. E., & Haugen, B. R. (2011) · PPAR Research · doi:10.1155/2011/171765 · Cited by 34
Self-citation
Signal transduction in the human thyrocyte and its perversion in thyroid tumors
Roger, P. P., van Staveren, W. C. G., Coulonval, K., Dumont, J. E., & Maenhaut, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.11.015 · Cited by 34
Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing
Kleiman, D. A., Buitrago, D., Crowley, M. J. P., Beninato, T. M., Veach, A. J., ZANZONICO, P. B., Jin, M. M., Fahey, T. J., & Zarnegar, R. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.053 · Cited by 33
Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAFV600E or wild-type BRAF
Antonello, Z. A., & Nucera, C. (2013) · Oncogene · doi:10.1038/onc.2013.544 · Cited by 33
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features
Gianì, F., Vella, V., Nicolosi, M. L., Fierabracci, A., Lotta, S., Malaguarnera, R., Belfiore, A., Vigneri, R., & Frasca, F. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4163 · Cited by 33
RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
Bagheri‐Yarmand, R., Busaidy, N. L., McBeath, E., Danysh, B. P., Evans, K. W., Moss, T. J., Akçakanat, A., Ng, P. K., Knippler, C. M., Golden, J. A., et al. (2021) · Cancers · doi:10.3390/cancers13194950 · Cited by 32
Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells
Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., & Lee, S. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.012 · Cited by 33
Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors
Mitmaker, E. J., Griff, N. J., Grogan, R. H., Sarkar, R., Kebebew, E., Duh, Q., Clark, O. H., & Shen, W. T. (2010) · Surgery · doi:10.1016/j.surg.2010.10.007 · Cited by 32
Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis
Jensen, K. E., Patel, A. D., Kłubo-Gwieździńska, J., Bauer, A. J., & Vasko, V. V. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0289 · Cited by 32
Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAF V600E Papillary Thyroid Carcinoma
Valvo, V., Iesato, A., Kavanagh, T. R., Priolo, C., Zsengellér, Z. K., Pontecorvi, A., Stillman, I. E., Burke, S. D., Liu, X., & Nucera, C. (2020) · Thyroid · doi:10.1089/thy.2020.0311 · Cited by 31
Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer
Lee, J. U., Huang, S., Lee, M. H., Lee, S. E., Ryu, M. J., Kim, S. J., Kim, Y. K., Kim, S. Y., Joung, K. H., Kim, J., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0010 · Cited by 34
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
Zhang, H., & Chen, D. (2018) · Thyroid Research · doi:10.1186/s13044-018-0057-6 · Cited by 31
Sunitinib Exerts Only Limited Effects on the Proliferation and Differentiation of Anaplastic Thyroid Cancer Cells
D’Agostino, M. N., Voce, P., Celano, M., Sponziello, M., Moretti, S., Maggisano, V., Verrienti, A., Durante, C., Filetti, S., Puxeddu, E., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0060 · Cited by 31
Development of p21 Activated Kinase-Targeted Multikinase Inhibitors That Inhibit Thyroid Cancer Cell Migration
Ma, Y., McCarty, S., Kapuriya, N. P., Brendel, V. J., Wang, C., Zhang, X., Jarjoura, D. G., Saji, M., Chen, C., & Ringel, M. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3937 · Cited by 31
Contribution of PKB/AKT signaling to thyroid cancer
Viglietto, G. (2010) · Frontiers in bioscience · doi:10.2741/3799 · Cited by 30
Activities of multiple cancer-related pathways are associated withBRAFmutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells
Liu, D., Liu, X., & Xing, M. (2013) · Cell Cycle · doi:10.4161/cc.26971 · Cited by 31
8-Chloro-Cyclic AMP and Protein Kinase A I-Selective Cyclic AMP Analogs Inhibit Cancer Cell Growth through Different Mechanisms
Lucchi, S., Calebiro, D., de Filippis, T., Grassi, E., Borghi, M. O., & Persani, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020785 · Cited by 30
HIF‐1α and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line
Mo, J., Choi, I. J., Jeong, W., Jeon, E.-H., & Ahn, S. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02181.x · Cited by 30
c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer
Li, Y., Li, X., Pu, J., Yang, Q., Guan, H., Ji, M., Shi, B., Chen, M., & Hou, P. (2018) · Thyroid · doi:10.1089/thy.2018.0183 · Cited by 30
Relaxin Enhances S100A4 and Promotes Growth of Human Thyroid Carcinoma Cell Xenografts
Radestock, Y., Willing, C., Kehlen, A., Hoang‐Vu, C., & Hombach‐Klonisch, S. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0307 · Cited by 30
Authentication of newly established human esophageal squamous cell carcinoma cell line (YM-1) using short tandem repeat (STR) profiling method
Khosravi, A., Khoshnia, M., Kazeminejad, V., & Asadi, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4133-4 · Cited by 30
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC
Occhi, G., Barollo, S., Regazzo, D., Bertazza, L., Galuppini, F., Guzzardo, V., Jaffrain‐Rea, M., Vianello, F., Ciato, D., Ceccato, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5194 · Cited by 30
The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells
Broecker‐Preuss, M., Becher-Boveleth, N., Müller, S. P., & Mann, K. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0303-8 · Cited by 30
Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
Chen, H., Luo, D., Zhang, L., Lin, X., Luo, Q., Yi, H., Wang, J., Yan, X., Li, B., Chen, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17398 · Cited by 29
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth
Weinlander, E. J., Somnay, Y. R., Harrison, A. D., Wang, C., Cheng, Y., Jaskula‐Sztul, R., Yu, X.-M., & Chen, H. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.02.042 · Cited by 29
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening
Anania, M. C., Gasparri, F., Cetti, E., Fraietta, I., Todoerti, K., Miranda, C., Mazzoni, M., Re, C. E., Colombo, R., Ukmar, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5282 · Cited by 28
Toward Secure and Trustworthy Cyberphysical Microfluidic Biochips
Tang, J., Ibrahim, M., Chakrabarty, K., & Karri, R. (2018) · IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems · doi:10.1109/tcad.2018.2855132 · Cited by 29
Alterations of regulatory factors and DNA methylation pattern in thyroid cancer
Iancu, I. V., Botezatu, A., Plesa, A., Huică, I., Fudulu, A., Albulescu, A., Bostan, M., Mihaila, M. A., Grancea, C., Manda, D. A., et al. (2020) · Cancer Biomarkers · doi:10.3233/cbm-190871 · Cited by 29
NADPH oxidase 1 is highly expressed in human large and small bowel cancers
Lu, J., Jiang, G., Wu, Y., Antony, S., Meitzler, J. L., Juhasz, A. N., Liu, H., Roy, K., Makhlouf, H. R., Chuaqui, R. F., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233208 · Cited by 30
The DREAM Protein Is Associated with Thyroid Enlargement and Nodular Development
Rivas, M., Mellström, B., Torres, B., Calı̀, G., Ferrara, A. M., Terracciano, D., Zannini, M., de Escobar, G. M., & Naranjo, J. R. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0466 · Cited by 29
Identification of Targets of Twist1 Transcription Factor in Thyroid Cancer Cells
Maro, G. D., Orlandella, F. M., Bencivenga, T. C., Salerno, P., Ugolini, C., Basolo, F., Maestro, R., & Salvatore, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3799 · Cited by 30
Characterization of Thyroid Cancer Cell Lines in Murine Orthotopic and Intracardiac Metastasis Models
Morrison, J. A., Pike, L. A., Lund, G., Zhou, Q., Kessler, B. E., Bauerle, K. T., Sams, S. B., Haugen, B. R., & Schweppe, R. E. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0219-0 · Cited by 29
Self-citation
BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas
Durante, C., Tallini, G., Puxeddu, E., Sponziello, M., Moretti, S., Ligorio, C., Cavaliere, A., Rhoden, K. J., Verrienti, A., Maranghi, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0283 · Cited by 31
Cancer stem cells as a potential therapeutic target in thyroid carcinoma
Vicari, L., Colarossi, C., Giuffrida, D., Maria, R. D., & Memeo, L. (2016) · Oncology Letters · doi:10.3892/ol.2016.4936 · Cited by 29
PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer
Lopez-Campistrous, A., Adewuyi, E. E., Benesch, M. G. K., Ko, Y. M., Lai, R. L., Thiesen, A., Dewald, J. W., Wang, P., Chu, K. P.-M., Ghosh, S., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.007 · Cited by 29
Thyroid Cancer Resistance to Vitamin D Receptor Activation Is Associated with 24-Hydroxylase Levels But Not the ff FokI Polymorphism
Sharma, V., Fretwell, D. L., Crees, Z. D., Kerege, A. A., & Klopper, J. P. (2010) · Thyroid · doi:10.1089/thy.2010.0096 · Cited by 28
Self-citation
A Metabolic Phenotype Based on Mitochondrial Ribosomal Protein Expression as a Predictor of Lymph Node Metastasis in Papillary Thyroid Carcinoma
Lee, J., Seol, M.-Y., Jeong, S., Lee, C. R., Ku, C. R., Kang, S., Jeong, J. J., Shin, D. Y., Nam, K., Lee, E. J., et al. (2015) · Medicine · doi:10.1097/md.0000000000000380 · Cited by 30
Distinct Genetic Alterations in the Mitogen-Activated Protein Kinase Pathway Dictate Sensitivity of Thyroid Cancer Cells to Mitogen-Activated Protein Kinase Kinase 1/2 Inhibition
Schweppe, R. E., Kerege, A. A., Sharma, V., Poczobutt, J. M., Gutierrez‐Hartmann, A., Grzywa, R. L., & Haugen, B. R. (2009) · Thyroid · doi:10.1089/thy.2008.0362 · Cited by 28
Self-citation
Targeting histone deacetylase in thyroid cancer
Russo, D., Durante, C., Bulotta, S., Puppin, C., Puxeddu, E., Filetti, S., & Damante, G. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.740013 · Cited by 28
Establishment and Characterization of Novel Human Primary and Metastatic Anaplastic Thyroid Cancer Cell Lines and Their Genomic Evolution Over a Year as a Primagraft
Garg, M., Okamoto, R., Nagata, Y., Kanojia, D., Venkatesan, S. S., Anand, M. T., Braunstein, G. D., SAID, J. W., Doan, N., Ho, Q. H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2359 · Cited by 26
Database of misidentified cell lines
Freshney, R. I. (2009) · International Journal of Cancer · doi:10.1002/ijc.24998 · Cited by 28
Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy
Reddi, H. V., Driscoll, C. B., Madde, P., Milosevic, D., Hurley, R. M., McDonough, S. J., Johnson, J. E. H., McIver, B., & Eberhardt, N. L. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.16 · Cited by 27
A novel HSP90 modulator with selective activity against thyroid cancers in vitro
Samadi, A. K., Loo, P., Mukerji, R., O'Donnell, G., Tong, X., Timmermann, B. N., & Cohen, M. S. (2009) · Surgery · doi:10.1016/j.surg.2009.09.028 · Cited by 27
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
Fallahi, P., Ferrari, S. M., Elia, G., Ragusa, F., Patrizio, A., Paparo, S. R., Marone, G., Galdiero, M. R., Guglielmi, G., Foddis, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.013 · Cited by 27
Normal vs cancer thyroid stem cells: the road to transformation
Zane, M., Scavo, E., Catalano, V., Bonanno, M., Todaro, M., Maria, R. D., & Stassi, G. (2015) · Oncogene · doi:10.1038/onc.2015.138 · Cited by 27
Possible Involvement of BRAFV600E in Altered Gene Expression in Papillary Thyroid Cancer
Watanabe, R., Hayashi, Y., Sassa, M., Kikumori, T., Imai, T., Kiuchi, T., & Murata, Y. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-329 · Cited by 27
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations
Preto, A., Gonçalves, J., Rebocho, A. P., Figueiredo, J., Meireles, A. M., Rocha, A. S., Vasconcelos, M. H., Seca, H., Seruca, R., Soares, P., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-387 · Cited by 27
Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome
Sloot, Y. J. E., Rabold, K., Netea, M. G., Smit, J. W. A., Hoogerbrugge, N., & Netea-Maier, R. T. (2019) · Oncogene · doi:10.1038/s41388-019-0685-x · Cited by 26
Photodynamic therapy enables tumor-specific ablation in preclinical models of thyroid cancer
Muhanna, N., Chan, H. H. L., Townson, J. L., Jin, C. S., Ding, L., Valic, M. S., Douglas, C. M., MacLaughlin, C. M., Chen, J., Zheng, G., et al. (2020) · Endocrine-Related Cancer · doi:10.1530/erc-19-0258 · Cited by 26
Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review)
Gao, Y., Li, B., Wu, X., Cui, J. R., & Han, J. (2014) · Oncology Reports · doi:10.3892/or.2014.2978 · Cited by 26
Gene Expression of Vitamin D Metabolic Enzymes at Baseline and in Response to Vitamin D Treatment in Thyroid Cancer Cell Lines
Bennett, R. G., Wakeley, S. E., Hamel, F. G., High, R., Korch, C. T., & Goldner, W. S. (2012) · Oncology · doi:10.1159/000342093 · Cited by 26
Self-citation
Regulator of calcineurin 1 modulates cancer cell migration in vitro
Espinosa, A. V., Shinohara, M., Porchia, L. M., Chung, Y. J., McCarty, S., Saji, M., & Ringel, M. D. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9251-1 · Cited by 26
Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target
Shirley, L. A., McCarty, S., Yang, M.-C., Saji, M., Zhang, X., Phay, J. E., Ringel, M. D., & Chen, C. (2015) · Surgery · doi:10.1016/j.surg.2015.10.016 · Cited by 26
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells.
Landriscina, M., Maddalena, F., Fabiano, A., Piscazzi, A., Macchia, O. L., & Cignarelli, M. (2010) · PubMed · Cited by 26
Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma
Haghpanah, V., Fallah, P., Naderi, M., Tavakoli, R., Soleimani, M., & Larijani, B. A. (2016) · Life Sciences · doi:10.1016/j.lfs.2015.12.057 · Cited by 26
The Ca2+–calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC
Rusciano, M. R., Salzano, M., Monaco, S., Sapio, M. R., Illario, M., Falco, V. D., Santoro, M. M., Campiglia, P., Pastore, L., Fenzi, G., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0214 · Cited by 26
Establishing Institutional Scores With the Rigor and Transparency Index: Large-scale Analysis of Scientific Reporting Quality
Menke, J., Eckmann, P., Ozyurt, I. B., Roelandse, M., Anderson, N., Grethe, J., Gamst, A., & Bandrowski, A. (2022) · Journal of Medical Internet Research · doi:10.2196/37324 · Cited by 25
Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes
Funk, W. D., Labat, I., Sampathkumar, J., Gourraud, P., Oksenberg, J. R., Rosler, E. S., Steiger, D., Sheibani, N., Caillier, S. J., Stache-Crain, B., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.10.001 · Cited by 27
In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF V600E mutation status and together with hypoxia-related proteins predicts aggressive behavior
Ilié, M., Lassalle, S., Long-Mira, É., Hofman, V., Zangari, J., Benaïm, G., Bozec, A., Guevara, N., Haudebourg, J., Birtwisle‐Peyrottes, I., et al. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1453-x · Cited by 25
PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio
Qiu, Y., Liao, L.-Y., Jiang, R., Xu, M., Xu, L., Chen, G. Y., & Liu, Z. (2019) · Scientific Reports · doi:10.1038/s41598-018-37648-7 · Cited by 25
Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10‐3 papillary thyroid cancer cells
Jung, Y. H., Lee, D. Y., Cha, W., Kim, B. H., Sung, M., Kim, K. H., & Ahn, S. (2016) · Head & Neck · doi:10.1002/hed.24461 · Cited by 24
Targeting autophagy in thyroid cancers
Wei, W., Hardin, H. A., & Luo, Q. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0502 · Cited by 25
MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer
Garcia, C. M., Buffet, C., Khattabi, L. E., Rizk‐Rabin, M., Perlemoine, K., Ragazzon, B., Bertherat, J. Y., Cormier, F., & Groussin, L. (2019) · Oncotarget · doi:10.18632/oncotarget.26798 · Cited by 25
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma
Limberg, J. N., Egan, C. E., Gray, K. D., Singh, M., Loewenstein, Z., Yang, Y., Riascos, M. C., Asadi, H. A., Safe, P., Eshaky, S. E., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0832 · Cited by 24

Authors: Schweppe, R. E., Klopper, J. P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J. A., Fagin, J. A., Marlow, L. A., Copland, J. A., Smallridge, R. C., & Haugen, B. R.
Affiliations: University of Colorado Cancer Center (US)
Memorial Sloan Kettering Cancer Center (US)
Mayo Clinic in Florida (US)
ORCID: Schweppe, Rebecca E.
Klopper, Joshua P.
Korch, Christopher
Pugazhenthi, Umarani
Benezra, Miriam
Knauf, Jeffrey A.
Fagin, James A.
Marlow, Laura A.
Copland, John A.
Haugen, Bryan R.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2008-11-01
Volume: 93
Issue: 11
Pages: 4331-4341
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2008-1102
PMC: PMC2582569
OpenAlex: W2027855079
Cited by: 563
References: 86
Citations by year: 2026: 3 · 2025: 7 · 2024: 11 · 2023: 28 · 2022: 9 · 2021: 21 · 2020: 22 · 2019: 27 · 2018: 33 · 2017: 33 · 2016: 38 · 2015: 40 · 2014: 29 · 2013: 47 · 2012: 54
FWCI: 38.71
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Florida Department of Health
Memorial Sloan-Kettering Cancer Center
National Institutes of Health (CA-04-6934, P 30CA046934)
University of Colorado Denver
Cancer Center, University of Colorado (P30 CA046934, CA046934)
National Cancer Institute (CA 046934, CA 50706, CA-72597, CA100560, R01CA100560, R01CA050706, R01CA072597, P30CA15083, P30CA015083, P30CA046934)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Identification and Quantification in Food
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords: thyroid cancer cell lines, cell line contamination, cell line misidentification, short tandem repeat profiling, DNA fingerprinting, TTF-1, PAX8
MeSH terms: Colonic Neoplasms, DNA, Neoplasm, Female, Humans, Male, Melanoma, Mutation, Neoplasm Proteins, RNA, Messenger, Thyroid Neoplasms, Reproducibility of Results, Adenocarcinoma, Follicular, Cell Culture Techniques, Polymorphism, Single Nucleotide, Gene Expression Profiling, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks